Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Inotuzumab ozogamicin: a CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,444 | Dovepress* | 15,834+ | 1,420 | 17,254 | |
PubMed Central* | 4,610 | 885 | 5,495 | ||
Totals | 20,444 | 2,305 | 22,749 | ||
*Since 24 July 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar